Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8841)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 6, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pharmacology and Therapeutics
ISSN
2150-5349
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kouroumalis E, Notas G. Primary biliary cirrhosis: From bench to bedside. World J Gastrointest Pharmacol Ther 2015; 6(3): 32-58 [PMID: 26261733 DOI: 10.4292/wjgpt.v6.i3.32] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i3/32.htm |
| Number | Citing Articles |
| 1 |
Sailaja Kamaraju, Jill Depke, Janice Povletich, Adam Currey, Elizabeth Weil. Cutaneous Metastasis due to Breast Cancer in a Patient with Primary Biliary Cirrhosis: A Case Report. Case Reports in Oncology 2016; 9(3): 718 doi: 10.1159/000452145
|
| 2 |
Aleksandar Arsenijevic, C. Randall Harrell, Crissy Fellabaum, Vladislav Volarevic. Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis. Analytical Cellular Pathology 2017; 2017: 1 doi: 10.1155/2017/7492836
|
| 3 |
Eduard Brunet, Leticia Hernández, Mireia Miquel, Jordi Sánchez-Delgado, Blai Dalmau, Oliver Valero, Mercedes Vergara, Meritxell Casas. Analysis of predictive response scores to treatment with ursodeoxycholic acid in patients with primary biliary cholangitis. Medicina Clínica (English Edition) 2019; 152(10): 377 doi: 10.1016/j.medcle.2019.03.009
|
| 4 |
C. Daniel De Magalhaes Filho, Michael Downes, Ron Evans. Bile Acid Analog Intercepts Liver Fibrosis. Cell 2016; 166(4): 789 doi: 10.1016/j.cell.2016.08.001
|
| 5 |
Ioannis Tsomidis, George Notas, Argyro Voumvouraki, Dimitrios Samonakis, Mairi Koulentaki, Elias Kouroumalis. Hepatic Lysosomal Enzyme Activity in Primary Biliary Cholangitis. Fibrosis 2023; 1(1): 1 doi: 10.35534/fibrosis.2023.10005
|
| 6 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Interplay of autophagy, apoptosis, and senescence in primary
biliary cholangitis. Exploration of Digestive Diseases 2023; 2(5): 223 doi: 10.37349/edd.2023.00028
|
| 7 |
Eduard Brunet, Leticia Hernández, Mireia Miquel, Jordi Sánchez-Delgado, Blai Dalmau, Oliver Valero, Mercedes Vergara, Meritxell Casas. Análisis de los índices predictores de respuesta al tratamiento con ácido ursodeoxicólico en pacientes con colangitis biliar primaria. Medicina Clínica 2019; 152(10): 377 doi: 10.1016/j.medcli.2018.08.002
|
| 8 |
Lixia Gao, Li Wang, Elena Woo, XiaoSong He, GaoXiang Yang, Christopher Bowlus, Patrick S.C Leung, M. Eric Gershwin. Clinical Management of Primary Biliary Cholangitis—Strategies and Evolving Trends. Clinical Reviews in Allergy & Immunology 2020; 59(2): 175 doi: 10.1007/s12016-019-08772-7
|
| 9 |
Emma R. Dorris, Simon J. Tazzyman, John Moylett, Nandhini Ramamoorthi, Jason Hackney, Michael Townsend, Munitta Muthana, Myles J. Lewis, Costantino Pitzalis, Anthony G. Wilson. The Autoimmune Susceptibility Gene C5orf30 Regulates Macrophage-Mediated Resolution of Inflammation. The Journal of Immunology 2019; 202(4): 1069 doi: 10.4049/jimmunol.1801155
|
| 10 |
Yuehong Lao, Xi Li, Wei Zhou, Haiqing Zhu, Yanting Jiang, Sihui Li, Min Jin, Jian Wang. The clinical value of the monocyte to high-density lipoprotein cholesterol ratio and alkaline phosphatase-to-platelet ratio in primary biliary cholangitis. Medicine 2023; 102(41): e35454 doi: 10.1097/MD.0000000000035454
|
| 11 |
Vânia Vilas-Boas, Eva Gijbels, Joop Jonckheer, Elisabeth De Waele, Mathieu Vinken. Cholestatic liver injury induced by food additives, dietary supplements and parenteral nutrition. Environment International 2020; 136: 105422 doi: 10.1016/j.envint.2019.105422
|